For: | Zhang SC, Yu MY, Xi L, Zhang JX. Tegafur deteriorates established cardiovascular atherosclerosis in colon cancer: A case report and review of the literature. World J Clin Cases 2019; 7(1): 89-94 [PMID: 30637257 DOI: 10.12998/wjcc.v7.i1.89] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v7/i1/89.htm |
Number | Citing Articles |
1 |
Zhongyi Dong, Bo Ni, Linxi Yang, Yujing Guan, Chunchao Zhu, Enhao Zhao, Gang Zhao, Xiang Xia, Zizhen Zhang. Efficacy and Safety of Camrelizumab in Combination with Docetaxel + S-1 Sequenced by Camrelizumab + S-1 for Stage III (PD-1+/MSI-H/EBV+/dMMR) Gastric Cancer: Study Protocol for a Single-Center, Prospective, Open-Label, Single-Arm Trial. Frontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.917352
|
2 |
Adam Buczkowski, Małgorzata Malinowska-Michalak, Artur Stepniak, Pawel Tokarz, Pawel Urbaniak, Bartlomiej Palecz. Calorimetric and spectroscopic studies of interactions of PPI G4 dendrimer with tegafur in aqueous solutions. Journal of Molecular Liquids 2021; 334: 116118 doi: 10.1016/j.molliq.2021.116118
|
3 |
Takuya Oyakawa, Zhensheng Hua, Aya Ebihara, Taro Shiga. A Rare Case of Reversible Cardiac Dysfunction Associated with Tegafur/Gimeracil/Oteracil (S-1) Therapy. International Heart Journal 2021; 62(3): 700 doi: 10.1536/ihj.20-651
|
4 |
Parul Grover, Kulbhushan Thakur, Monika Bhardwaj, Lovekesh Mehta, Soom Nath Raina, Vijay Rani Rajpal. Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical
Translation. Current Topics in Medicinal Chemistry 2024; 24(12): 1050 doi: 10.2174/0115680266282518231231075311
|